Free shipping on all orders over $ 500

 About 1 result found for searched term "2079939-05-0" (0.66 seconds)

Cat.No.  Name Target
M21577 Sirpiglenastat Others
DRP-104
Sirpiglenastat (DRP-104) is a broad acting glutamine (glutamine) antagonist. Sirpiglenastat has anticancer effects by directly targeting tumor metabolism and simultaneously inducing an effective antitumor immune response.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.